Off-Label Use of Ketamine for the Treatment of Patients With Mood Disorders - Psychiatry Advisor

Psychiatry AdvisorOff-Label Use of Ketamine for the Treatment of Patients With Mood DisordersPsychiatry AdvisorThe American Psychiatric Association Council of Research Task Force on Novel Biomarkers and Treatments recently issued a consensus statement on the off-label use of ketamine for the treatment of mood disorders. The consensus contributors emphasized ...